Skip to content

Clinical trials

Phase 2 Spondylitis, Ankylosing trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Spondylitis, Ankylosing Phase: Phase 2 Country / region: China Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20201
20213
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Akeso1
Celgene1
Inmagene LLC1
Lynk Pharmaceuticals Co., Ltd1
Shanghai Junshi Bioscience Co., Ltd.1
Shanghai Pharmaceuticals Holding Co., Ltd1
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.1
Suzhou Zelgen Biopharmaceuticals Co.,Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Spondylitis, Ankylosing8
Arthritis1
Bone Diseases1
Joint Diseases1
Musculoskeletal Diseases1
Spinal Diseases1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.